WEST FRANKFORT — The Old King Coal Festival is still held here every year, though coal is no longer king.
This community in deep southern Illinois was once awash with so-called black diamonds. The boom continued into the 1970s, but has declined steadily since. Neighborhoods just outside the city limits are still known by the numbered names of forgotten mines: No. 9, No. 11, No. 15, No. 18.
The result of the coal decline is a shifting economy and a shrinking population. West Frankfort had nearly 15,000 residents decades ago but today is home to barely 7,000 souls. Once-bustling Main Street — which at one time boasted three competing movie theaters — is now peppered with vacant, crumbling buildings.
“There were 75 mines within a 50-mile radius of West Frankfort,” said Leonard Hopkins, a native of the community who still lives here.
Now there are only a handful. Several factors are responsible for the downturn, including government regulation, labor strife and the depletion of the coal seams.
Empty storefronts line Main Street in West Frankfort. It is among many communities in southern Illinois affected by the decline of the coal industry.
NAT WILLIAMS, ILLINOIS FARMER TODAY
The boom-and-bust nature of the mining industry is certainly not unique to this area. The Old West was full of gold towns that in the New West are ghost towns. Many of those — such as Deadwood, South Dakota — have become tourist attractions that provide a new type of income. Economic recovery in the Coal Belt is more challenging.
“The area as a whole will continue to lose working population,” said Hopkins, a retired executive with Southern Illinois Power Cooperative, which depends on coal to deliver electricity to farms, homes and businesses in the region.
The Clean Air Act, passed in 1970, may have marked the beginning of the end for the coal industry in the region. The high-sulfur coal mined here was targeted by environmental regulation, and the rules were made more and more stringent over the years by the EPA.
“What started out as a sulfur dioxide limit of 6.8 pounds per million BTU is now around 0.2 pounds per million,” said Hopkins, who was vice president of fuel and environmental safety with the co-op. “What started out as 1.2 pounds of nitrogen oxide per million BTU is now down to 0.12 or something like that. It’s crazy. It’s 90% lower over time.”
The green energy push today may pound more nails into the coffin. Illinois Gov. J.B. Pritzker recently signed a bill calling for the end of coal as a power source and mandating only clean energy production by 2050.
“There used to be a lot of resistance to alternative energy like solar from communities because they felt an allegiance to coal companies,” said Rick Linton, director of the Franklin County Economic Development Corp. “That’s understandable, because so much was built by coal. But that seems to be dissipating.”
Still, the region is ill-prepared to transition from coal, gas and oil to solar and wind. While many politicians claim that the new economy will provide green jobs, those jobs may not materialize in areas like southern Illinois.
“For us to get into clean energy technology we need an available, capable workforce,” Linton said. “We have a lot of unemployed people, but a lot of companies are looking for somebody with a technical background or education. We also don’t have the population base to draw from. That puts us in a weak position when it comes to attracting companies.”
The region does have good infrastructure, including 18,900-acre Rend Lake, the second-largest reservoir in Illinois. Interstate highways crisscross the region. Commercial airports in Carbondale and Marion serve as commuter hubs. The Mississippi, Ohio and Wabash rivers border southern Illinois. The nearby Shawnee National Forest — the only national forest in Illinois — provides various recreational opportunities.
“We’re really blessed with water and transportation,” Linton said. “But we’re not going to attract retail into the area because we don’t have a population base to support consumer spending.”
Meanwhile, the region grapples with the loss of jobs and lack of economic growth. The closing of coal mines also affects ancillary businesses, such as machine shops and other service industries.
Illinois Basin Enterprises, which installed and serviced conveyor belts in mines across the region, was forced to shut down a few years ago.
Gov. J.B. Pritzker joins the British Consulate-General Chicago for the Road to COP26: Celebrating Illinois Climate Action ahead of the United Nations Climate Summit in Glasgow.
“We got up to about a dozen employees,” said Randy Manning, owner of the business, which was based in nearby Benton, the Franklin County seat. “Many of the mines were running three shifts.”
The industry began suffering in the late 1980s when the price of coal fell dramatically.
“The coal market dropped out,” Manning said. “Union mines were asking the workers to take some cuts. They didn’t want to do that. Some of the coal mines had to shut down. Imagine all the taxes that were lost.”
In some ways, the coal industry is a victim of its own success. Longwall mining — a method in which machines chew large swaths of coal underground— replaced room-and-pillar mining, in which pillars of coal were left to help support the top. That meant fewer workers and more efficient production, shortening the lives of mines.
“When I started, coal didn’t produce like they do now,” Manning said. “Mainline belts were 42 to 48 inches. Now many are 84 inches wide. Longwall mines still employed quite a few people, but they produced so much coal that the life of the mine would shorten.”
Hopkins believes those pushing for the elimination of fossil fuels may be sorry in the near future.
“The country as a whole will be hurting for electricity in 10 or 15 years,” he said. “It’s becoming clear that the sun doesn’t always shine and the wind doesn’t always blow. It’s tough to compete with coal.”
What to know about ‘mix-and-match’ COVID-19 vaccine boosters
What does this authorization actually mean right now?
Updated
The authorization from the FDA is a crucial step before full approval and before more people in the U.S. can start receiving a booster shot. A separate advisory committee for the Centers for Disease Control and Prevention is scheduled to vote Thursday on the use of Moderna and J&J boosters.
The only one of the three vaccines available in booster form is Pfizer-BioNTech and only for those 65 years and older or vulnerable Americans. Vulnerable may mean you live in a long-term care facility, work in a high-risk location, or have underlying condition like a chronic lung disease or obesity.
“It’s a little confusing,” said Dr. Sajal Tanna, an infectious disease physician at Northwestern Memorial Hospital and assistant professor at Northwestern’s school of medicine. “It’s just hard for laypeople and even physicians to know the whole process. The FDA says OK, but we can’t actually practice it yet. We have to wait for the CDC.”
Since mid-August, the United States has already been administering third Moderna and Pfizer doses to a small group of patients who are moderately to highly immunocompromised, including organ transplant recipients, some cancer patients and folks who take certain immunosuppressant medications. But this has only affected people with a very narrow list of conditions. The third doses serve a different purpose from booster shots, which are being administered to a wider base of people.
Photo by Terrence Antonio James, Chicago Tribune
What does the authorization mean for each type of vaccine recipient?
Updated
For those who initially received the Moderna or Pfizer vaccine, officials said one generally should stick with the same vaccine series, primarily because there is no evidence of marked benefits, though the FDA announcement made no recommendation to that effect.
Some reasons to switch to a different brand might be if the individual had a particularly bad reaction to the mRNA technology included in both Moderna or Pfizer vaccines or if availability of their initial series is limited. A preliminary study discussed by an FDA advisory committee showed switching would be all right if the initial brand isn’t currently available.
However, for those who took the one-dose J&J vaccine, early research suggests taking the Moderna vaccine as a booster yielded the greatest antibody increase. The study showed that a second shot using the Moderna vaccine triggered a 76-fold increase in antibody levels. By contrast, a Pfizer booster increased antibody levels 35-fold, and the coordinating J&J booster yielded only a fourfold increase.
“If the FDA recommends mix and match, then I think the most promising thing is that people who’ve got the J&J would have the ability to switch over to Moderna or Pfizer for their boosters,” Tanna said.
Safety concerns may also play into some J&J recipients’ decision to switch to an mRNA booster shot. According to Yale Medicine, out of 9 million doses administered by May, 28 people developed a rare blood clotting disorder, three of whom died. The side effect tended to be slightly more common in women under 50 years old.
In July, the FDA also attached a warning for a rare neurological condition called Guillain-Barré syndrome to the J&J vaccine. Again, the cases were exceedingly rare with about 100 suspected cases primarily among men aged 50 years and older.
Associated Press File Photo
How conclusive is the study the FDA committee is basing their authorization partially on?
Updated
The study, while “encouraging,” is by no means conclusive, according to Tanna. The results of the study have yet to be formally peer reviewed and published. It is currently in preprint form, a version of a scientific study posted publicly prior to formal peer review.
Tanna pointed out a few caveats to keep in mind for the study. The number of people who participated in the study was relatively small, with about 50 people receiving a specific combination of original series and booster.
The study was also conducted before the Delta variant became the dominant strain of COVID-19, Tanna said. Additionally, the study primarily looked at antibody counts, which are a good measure of general resistance; however, it didn’t look at the T-cell response, which is harder to measure but is indicative of how well a vaccine limits the severity of the illness.
“The study wasn’t necessarily powered to say that one vaccination strategy of mixing and matching is better than another. And I think that’s what we all want, right?” Tanna said. “Tell me which ones to get, so I have the most protection, and I don’t think we can draw those conclusions just yet.”
Photo by Clay Jackson, Herald & Review
How does this authorization affect different age groups?
Updated
Until the CDC rules on Moderna and J&J, the only booster shot that people in the U.S. are allowed to receive at present is a Pfizer booster if the recipient is vulnerable to COVID-19 or older than 65.
The FDA authorized Moderna half-dose booster shots Thursday for those aged 65 years and older or vulnerable people, which may be administered six months after the first set of doses. They then also authorized a J&J booster for all adults.
The agency’s authorization makes it so that anyone 18 and older who initially received the J&J vaccine could potentially get any other brand of booster vaccine only two months after their single dose.
The FDA’s announcement stressed that there is no need for recipients of one of the mRNA vaccines to get a booster if they are younger than 65 years old and do not qualify as vulnerable to the disease.
Photo by Vashon Jordan Jr., Chicago Tribune
Is vaccine supply a concern?
Updated
In a way, yes. The country and each state likely has a deep stockpile of vaccine, even as the rest of the world struggles with shortages. However, the concern lies in which vaccines are available and where. Those who are unable to find a booster near them that corresponds with their original series, based on the new authorization, would be able to switch to a vaccine that is more readily available.
The interchangeability is expected to be particularly useful in nursing homes and other institutional settings where residents have received different shots over time.
Tanna said that, in her experience, all of her patients who are eligibly for the Pfizer booster have been able to find one easily and within the area.
Photo by Brian Cassella, Chicago Tribune
Are the boosters a full or half-dose?
Updated
This is where the data gets confusing and a decision more difficult. The authorized Pfizer booster shot is one full dose of the vaccine.
The Moderna booster, on the other hand, is only recommended as a half-dose of the original full shot. The study that suggests a Moderna booster may provide a 76-fold increase in antibody levels when mixed with a J&J vaccination used a full-strength dose as a booster. It is unclear if the half-dose of Moderna that the FDA authorized would provide the same result without further testing, Tanna said.
Tanna said she is hopeful that this authorization will provide some much needed clarity and guidance for those who initially received the J&J vaccine.
“All these recommendations that have been made for additional doses or for booster vaccinations, the people who got Johnson and Johnson have felt left behind, especially if they’re high risk, and they really haven’t had the guidance they need,” Tanna said.
Photo Brian Cassella, Chicago Tribune
Region: Northern,Region: Kankakee,News
via http://www.newsbug.info – RSS Results of type article https://ift.tt/2FPnTti
November 11, 2021 at 04:06PM
